A detailed history of Appian Way Asset Management LP transactions in Dario Health Corp. stock. As of the latest transaction made, Appian Way Asset Management LP holds 1,375,880 shares of DRIO stock, worth $1.47 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
1,375,880
Previous 1,334,142 3.13%
Holding current value
$1.47 Million
Previous $2.04 Million 19.79%
% of portfolio
0.42%
Previous 0.54%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.09 - $1.9 $45,494 - $79,302
41,738 Added 3.13%
1,375,880 $1.64 Million
Q1 2024

May 15, 2024

BUY
$1.4 - $2.55 $16,377 - $29,829
11,698 Added 0.88%
1,334,142 $2.04 Million
Q4 2023

Feb 14, 2024

BUY
$1.0 - $3.39 $32,448 - $109,998
32,448 Added 2.52%
1,322,444 $2.27 Million
Q3 2023

Nov 14, 2023

BUY
$2.6 - $4.23 $22,978 - $37,384
8,838 Added 0.69%
1,289,996 $4.23 Million
Q2 2023

Aug 14, 2023

BUY
$3.2 - $4.33 $826,803 - $1.12 Million
258,376 Added 25.26%
1,281,158 $5.14 Million
Q1 2023

May 15, 2023

SELL
$3.79 - $6.22 $459,332 - $753,839
-121,196 Reduced 10.59%
1,022,782 $4.21 Million
Q4 2022

Feb 14, 2023

BUY
$3.53 - $5.49 $442,976 - $688,934
125,489 Added 12.32%
1,143,978 $4.9 Million
Q3 2022

Nov 14, 2022

BUY
$3.74 - $7.09 $391,031 - $741,287
104,554 Added 11.44%
1,018,489 $4.72 Million
Q2 2022

Aug 15, 2022

SELL
$4.33 - $7.45 $149,610 - $257,412
-34,552 Reduced 3.64%
913,935 $5.61 Million
Q1 2022

May 16, 2022

BUY
$5.84 - $13.61 $2.55 Million - $5.94 Million
436,500 Added 85.26%
948,487 $5.54 Million
Q4 2021

Feb 14, 2022

BUY
$12.52 - $19.02 $3.69 Million - $5.61 Million
294,785 Added 135.72%
511,987 $6.64 Million
Q3 2021

Nov 15, 2021

BUY
$10.47 - $20.87 $2.27 Million - $4.53 Million
217,202 New
217,202 $2.97 Million

Others Institutions Holding DRIO

About DarioHealth Corp.


  • Ticker DRIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 23,295,000
  • Market Cap $24.9M
  • Description
  • DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common...
More about DRIO
Track This Portfolio

Track Appian Way Asset Management LP Portfolio

Follow Appian Way Asset Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Appian Way Asset Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Appian Way Asset Management LP with notifications on news.